摘要
脊肌萎缩症(SMA)是最常见的遗传性神经退行性疾病,导致婴儿死亡。SMA是由运动神经元1生存基因缺失或突变引起的基因(SMN1),从而导致运动神经元的存活(SMN)蛋白水平降低。SMN蛋白缺乏优先影响α-运动神经元,导致其退化,肢体和躯干的肌肉萎缩之后,死于严重的疾病。最近的研究表明,SMN蛋白的消耗影响其他组织包括骨骼肌、心脏的功能,自主神经和肠神经系统、代谢/内分泌(例如胰腺)、淋巴结、骨和生殖系统。在这篇综述中,我们总结了研究讨论在不同的细胞和组织类型及其在SMA疾病病因的背景下参与SMN蛋白的功能。总之,这些研究表明,SMA是多器官的疾病,这同时表明,真正有效的疾病干预可能需要的SMN蛋白水平修正。
关键词: 基因治疗,运动神经元,神经肌肉疾病,脊髓性肌萎缩,运动神经元存活,治疗学。
Current Molecular Medicine
Title:Spinal Muscular Atrophy: More than a Disease of Motor Neurons?
Volume: 16 Issue: 9
Author(s): L. A. Nash, J. K. Burns, J. Warman Chardon, R. Kothary, R. J. Parks
Affiliation:
关键词: 基因治疗,运动神经元,神经肌肉疾病,脊髓性肌萎缩,运动神经元存活,治疗学。
摘要: Spinal muscular atrophy (SMA) is the most common genetically inherited neurodegenerative disease resulting in infant mortality. SMA is caused by genetic deletion or mutation in the survival of motor neuron 1 (SMN1) gene, which results in reduced levels of the survival of motor neuron (SMN) protein. SMN protein deficiency preferentially affects α- motor neurons, leading to their degeneration and subsequent atrophy of limb and trunk muscles, progressing to death in severe forms of the disease. More recent studies have shown that SMN protein depletion is detrimental to the functioning of other tissues including skeletal muscle, heart, autonomic and enteric nervous systems, metabolic/endocrine (e.g. pancreas), lymphatic, bone and reproductive system. In this review, we summarize studies discussing SMN protein’s function in various cell and tissue types and their involvement in the context of SMA disease etiology. Taken together, these studies indicate that SMA is a multi-organ disease, which suggests that truly effective disease intervention may require body-wide correction of SMN protein levels.
Export Options
About this article
Cite this article as:
L. A. Nash, J. K. Burns, J. Warman Chardon, R. Kothary, R. J. Parks , Spinal Muscular Atrophy: More than a Disease of Motor Neurons?, Current Molecular Medicine 2016; 16 (9) . https://dx.doi.org/10.2174/1566524016666161128113338
DOI https://dx.doi.org/10.2174/1566524016666161128113338 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
CNS & Neurological Disorders - Drug Targets Neural Stem Cell Transplantation and CNS Diseases
CNS & Neurological Disorders - Drug Targets Development and Applications of Non-HIV-Based Lentiviral Vectors in Neurological Disorders
Current Gene Therapy Molecular Strategies for the Treatment of Huntingtons Disease
Current Pharmacogenomics Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates
Current Genomics Nutritional Support in Cancer
Current Nutrition & Food Science Myalgic Encephalomyelitis: Symptoms and Biomarkers
Current Neuropharmacology Transglutaminase Activity as a Possible Therapeutical Target in Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) The Small Heat Shock Protein HspB8: Role in Nervous System Physiology and Pathology
CNS & Neurological Disorders - Drug Targets Acetylome Regulation by Sirtuins in the Brain: From Normal Physiology to Aging and Pathology
Current Pharmaceutical Design Fish and Apoptosis: Studies in Disease and Pharmaceutical Design
Current Pharmaceutical Design Expanding our Understanding of Polyglutamine Disease Through Transgenic Mice
Current Genomics Protein Aggregation and Its Consequences for Human Disease
Protein & Peptide Letters Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia
CNS & Neurological Disorders - Drug Targets Polyphenols and Stem Cells for Neuroregeneration in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook
Current Pharmaceutical Design Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
Current Cancer Drug Targets Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents A Genetic Dissection of Antipsychotic Induced Movement Disorders
Current Medicinal Chemistry